Carlet J
Intensive Care Unit, Fondation Hôpital Saint Joseph, Paris, France.
Infect Dis Clin North Am. 1999 Jun;13(2):483-94, xi. doi: 10.1016/s0891-5520(05)70087-8.
Any delay in the management of infection is deleterious, especially in patients whose illness is severe. It is of paramount importance to shorten this delay. This article emphasizes the different ways to reach this goal, including the use of new biologic markers, such as cytokines or procalcitonin.
感染治疗的任何延误都是有害的,尤其是对病情严重的患者。缩短这种延误至关重要。本文强调了实现这一目标的不同方法,包括使用新的生物标志物,如细胞因子或降钙素原。